Cigna Group $CI Shares Sold by Swedbank AB

Key Points

• Swedbank AB decreased its holdings in Cigna Group by 0.1% in Q1, now owning 883,337 shares worth approximately $290.6 million.
• Cigna recently reported strong quarterly earnings, with $7.20 EPS, surpassing estimates and showing an 11% year-over-year revenue growth.
• The company declared a quarterly dividend of $1.51, which translates to an annualized yield of 2.0% based on the current stock price.

Swedbank AB lowered its holdings in Cigna Group (NYSE:CI - Free Report) by 0.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 883,337 shares of the health services provider's stock after selling 1,069 shares during the period. Swedbank AB owned approximately 0.33% of Cigna Group worth $290,618,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CI. Flaharty Asset Management LLC acquired a new stake in Cigna Group during the 1st quarter valued at $28,000. 1248 Management LLC acquired a new stake in Cigna Group during the 1st quarter valued at $29,000. Activest Wealth Management grew its holdings in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares in the last quarter. Putney Financial Group LLC acquired a new stake in Cigna Group during the 4th quarter valued at $36,000. Finally, Saudi Central Bank acquired a new stake in Cigna Group during the 1st quarter valued at $36,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Trading Up 1.2%

NYSE CI opened at $305.93 on Friday. Cigna Group has a 12 month low of $256.89 and a 12 month high of $370.83. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company has a market capitalization of $81.66 billion, a price-to-earnings ratio of 16.70, a price-to-earnings-growth ratio of 0.89 and a beta of 0.48. The company's fifty day moving average price is $295.81 and its two-hundred day moving average price is $312.08.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period last year, the firm posted $6.72 EPS. The company's revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group's dividend payout ratio (DPR) is presently 32.97%.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the firm's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on CI. Wall Street Zen lowered shares of Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Barclays raised their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an "overweight" rating in a report on Thursday, September 4th. TD Cowen raised shares of Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Wells Fargo & Company reduced their price objective on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Finally, Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a research note on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $374.76.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.